Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar;30(2):604-614.
doi: 10.1111/odi.14317. Epub 2022 Aug 10.

Prevalence of, and risk factors for, dental sequelae in adolescents who underwent cancer therapy during childhood

Affiliations
Free article

Prevalence of, and risk factors for, dental sequelae in adolescents who underwent cancer therapy during childhood

Judit Rabassa-Blanco et al. Oral Dis. 2024 Mar.
Free article

Abstract

Introduction: The increase in survival rates in children treated for cancer has been accompanied by a rise in sequelae in permanent teeth. The aim of the study was to correlate the type of cancer therapy administered to patients during early childhood and the dental sequelae recorded in survivors.

Material and methods: Single-center retrospective cohort study carried out at the Children's University Hospital of Sant Joan de Déu in Barcelona, Spain. Hundred and nine patients who had received cancer treatment during early childhood were randomly examined and grouped according to diagnosis and cancer therapy received. The type of therapy was correlated with the number and severity of dental lesions that patients presented in adolescence.

Results: Dental sequelae of some kind were present in 85.3% of patients. Microdontia was the most prevalent (52.3%). Treatment with alkylating agents had a relative risk of presenting moderate lesions of 3.36 (1.18-9.60), and one of 2.29 (1.07-4.91) of presenting severe lesions. Topoisomerase inhibitors and cytotoxic antibiotics presented relative risks of 1.6 (1.07-2.38) and 2.08 (1.02-4.26) of root alterations and agenesis, respectively.

Conclusions: Treatment with alkylating agents together with cytotoxic antibiotics and topoisomerase inhibitors was associated with a higher relative risk of microdontia, agenesis, and root shortening.

Keywords: adverse effects; chemotherapy; childhood cancer survivors; odontogenic disorders; tooth formation anomalies.

PubMed Disclaimer

References

REFERENCES

    1. Busenhart, D. M., Erb, J., Rigakos, G., Eliades, T., & Papageorgiou, S. N. (2018). Adverse effects of chemotherapy on the teeth and surrounding tissues of children with cancer: A systematic review with meta-analysis. Oral Oncology, 83, 64-72. https://doi.org/10.1016/j.oraloncology.2018.06.001
    1. Çetiner, D., Çetiner, S., Uraz, A., Alpaslan, G. H., Alpaslan, C., Toygar Memikoğlu, T. U., & Karadeniz, C. (2019). Oral and dental alterations and growth disruption following chemotherapy in long-term survivors of childhood malignancies. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 27(5), 1891-1899. https://doi.org/10.1007/s00520-018-4454-0
    1. Dury, D. C., Roberts, M. W., Miser, J. S., & Folio, J. (1984). Dental root agenesis secondary to irradiation therapy in a case of rhabdomyosarcoma of the middle ear. Oral Surgery, Oral Medicine, and Oral Pathology, 57(6), 595-599. https://doi.org/10.1016/0030-4220(84)90278-0
    1. Effinger, K. E., Migliorati, C. A., Hudson, M. M., McMullen, K. P., Kaste, S. C., Ruble, K., Guilcher, G. M., Shah, A. J., & Castellino, S. M. (2014). Oral and dental late effects in survivors of childhood cancer: A Children's oncology group report. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 22(7), 2009-2019. https://doi.org/10.1007/s00520-014-2260-x
    1. Elzembely, M. M., Dahlberg, A. E., Pinto, N., Leger, K. J., Chow, E. J., Park, J. R., Carpenter, P. A., & Baker, K. S. (2019). Late effects in high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell rescue. Pediatric Blood & Cancer, 66(1), e27421. https://doi.org/10.1002/pbc.27421

Substances